Critical Analysis: Upexi (NASDAQ:UPXI) vs. Paranovus Entertainment Technology (NASDAQ:PAVS)

Paranovus Entertainment Technology (NASDAQ:PAVS) and Upexi (NASDAQ:UPXI) are both small-cap consumer defensive companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, earnings, institutional ownership, risk, analyst recommendations and valuation.

Volatility and Risk

Paranovus Entertainment Technology has a beta of 0.06, suggesting that its share price is 94% less volatile than the S&P 500. Comparatively, Upexi has a beta of 0.49, suggesting that its share price is 51% less volatile than the S&P 500.

Profitability

This table compares Paranovus Entertainment Technology and Upexi’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Paranovus Entertainment Technology	N/A	N/A	N/A
Upexi	-22.63%	-40.72%	-18.07%

Institutional and Insider Ownership

0.2% of Paranovus Entertainment Technology shares are owned by institutional investors. Comparatively, 5.7% of Upexi shares are owned by institutional investors. 15.6% of Paranovus Entertainment Technology shares are owned by company insiders. Comparatively, 41.6% of Upexi shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Valuation & Earnings

This table compares Paranovus Entertainment Technology and Upexi’s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Paranovus Entertainment Technology	$98.15 million	0.09	-$71.74 million	N/A	N/A
Upexi	$80.68 million	0.13	-$16.93 million	N/A	N/A

Upexi has lower revenue, but higher earnings than Paranovus Entertainment Technology.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Paranovus Entertainment Technology and Upexi, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Paranovus Entertainment Technology	0	0	0	0	N/A
Upexi	0	1	0	0	2.00

Upexi has a consensus price target of $1.25, suggesting a potential upside of 148.51%. Given Upexi’s higher probable upside, analysts clearly believe Upexi is more favorable than Paranovus Entertainment Technology.

Summary

Upexi beats Paranovus Entertainment Technology on 6 of the 10 factors compared between the two stocks.

About Paranovus Entertainment Technology

Paranovus Entertainment Technology Ltd. engages in the research, development, manufacture, and sale of nutraceutical and dietary supplement products in the People's Republic of China and internationally. The company's product category includes lucidum spore powders, cordyceps mycelia, Ejiao products, American ginseng products, other traditional Chinese herbal and animal extracts, vitamins, minerals, and amino acids. It also offers product marketing and e-commerce agency operation services under the Happy Buy platform to small and middle size businesses; and e-commerce solutions, internet information, and advertising services to the online stores or manufactures. In addition, the company provides secure transaction environment, automobile procurement, and financial services for automobile manufacturers under the Taochejun automobile sales platform. It sells its products through distributors, large-scale chain drugstores, malls, and supermarkets under the Happiness brand. The company was formerly known as Happiness Development Group Limited and changed its name to Paranovus Entertainment Technology Ltd. in March 2023. The company was founded in 2004 and is headquartered in Nanping, the People's Republic of China.

About Upexi

Upexi, Inc. manufactures and sells various branded products in the health, wellness, pet, beauty, and other markets. The company was formerly known as Grove, Inc. and changed its name to Upexi, Inc. in August 2022. The company was incorporated in 2018 and is headquartered in Clearwater, Florida.